Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...

Intrigued by the recent news about Atlanta Hawks’ star Trae Young and his unexpected time off the court? With his injury ...

Most women don’t know what’s going to happen during perimenopause. Smart-ring manufacturers are stepping in to provide data ...

It quickly became clear that we needed to transform the medical organization and bring clinical site-facing activities back to DiaMedica because ... success for the ReMEDy2 trial and accelerate our ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello, ladies and gentlemen, and welcome to the Autolus ...

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers ...

Today, we honor our local veterans and recognize their contributions to our Big Country community. Our 2024 Veterans Voices ...

Detailed price information for Mink Therapeutics Inc (INKT-Q) from The Globe and Mail including charting and trades.